{
    "code": "02026026",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02026026",
    "time": "2022-01-14 06:05:44",
    "許可證字號": "衛署藥輸字第026026號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/05\/08",
    "發證\/登錄日期": "102\/05\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202602601",
    "中文品名": "艾諾幸&quot;艾威群&quot;注射液2毫克\/毫升",
    "英文品名": "Doxorubicin &quot;Alvogen&quot; solution for Injection 2mg\/ml",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肺癌。",
    "劑型": "270注射劑",
    "包裝": "5,10,25,50毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DOXORUBICIN HCL",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市大安區信義路三段149號15樓",
    "主製造廠": [
        {
            "": "GREECE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Doxorubicin_Round_7_ARTDB006356P_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=006&Type=9"
        },
        {
            "title": "PIL_6106_Round_6-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=005&Type=9"
        },
        {
            "title": "4.Doxorubicin labeling-2016-06-17-105-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=004&Type=9"
        },
        {
            "title": "Doxorubucin_Round_2_ARTDB002164L_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=014&Type=8"
        },
        {
            "title": "Doxorubicin_Round_5_ARTDB006352C_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=013&Type=8"
        },
        {
            "title": "10mg_5ml_Label_6102_Round_4-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=012&Type=8"
        },
        {
            "title": "10mg_5ml_Carton_6102_Round_4-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=011&Type=8"
        },
        {
            "title": "020260260002-2014-06-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026026&Seq=010&Type=8"
        }
    ]
}